AVITA Medical is a publicly listed (NASDAQ: RCEL, ASX:AVH) regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications. AVITA Therapeutics’ patented and proprietary collection and application technology provides innovative treatment solutions derived from the regenerative properties of a patient’s own skin. The medical devices work by preparing a RES® REGENERATIVE EPIDERMAL SUSPENSION, an autologous suspension comprised of the patient’s skin cells necessary to regenerate natural healthy epidermis. This autologous suspension is then sprayed onto the areas of the patient requiring treatment.
Location: United States, California, Santa Clarita
Employees: 51-200
Total raised: $159.1M
Founded date: 2008
Investors 1
| Date | Name | Website |
| 25.10.2023 | OrbiMed | orbimed.co... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 19.10.2023 | - | $90M | OrbiMed |
| 24.02.2021 | - | $69.1M | - |
Mentions in press and media 19
| Date | Title | Description | Source |
| 12.03.2024 | Global Skin Grafting Device Market Size to Surpass US$ 1,519... | Global Skin Grafting Device Market size is expected to reach US$ 1,519.0 Million by 2030, from US$ 9... | einpresswi... |
| 19.10.2023 | AVITA Medical Secures up to $90 million of Non-Dilutive Debt... | - | orbimed.co... |
| 18.10.2023 | AVITA Medical Announces Preliminary Third Quarter 2023 Finan... | - | globenewsw... |
| 26.06.2023 | AVITA Medical Rejoins the Russell 3000 Index | /EIN News/ -- VALENCIA, Calif., and MELBOURNE, Australia, June 26, 2023 (GLOBE NEWSWIRE) -- AVITA Me... | einpresswi... |
| 16.06.2023 | AVITA Medical Announces FDA Approval of RECELL for Skin Repi... | /EIN News/ -- VALENCIA, Calif. and MELBOURNE, Australia, June 16, 2023 (GLOBE NEWSWIRE) -- AVITA Med... | einpresswi... |
| 15.06.2023 | AVITA Medical Announces Appointment of David O’Toole as Chie... | /EIN News/ -- VALENCIA, Calif. and MELBOURNE, Australia, June 15, 2023 (GLOBE NEWSWIRE) -- AVITA Med... | einpresswi... |
| 08.06.2023 | AVITA Medical Announces FDA Approval of RECELL for Treatment... | /EIN News/ -- VALENCIA, Calif. and MELBOURNE, Australia, June 07, 2023 (GLOBE NEWSWIRE) -- AVITA Med... | einpresswi... |
| 15.05.2023 | AVITA Medical to Host Investor Webinar Briefing | /EIN News/ -- VALENCIA, Calif. and MELBOURNE, Australia, May 15, 2023 (GLOBE NEWSWIRE) -- AVITA Medi... | einpresswi... |
| 11.05.2023 | AVITA Medical Reports First Quarter Financial Results and Af... | /EIN News/ -- VALENCIA, Calif. and MELBOURNE, Australia, May 11, 2023 (GLOBE NEWSWIRE) -- AVITA Medi... | einpresswi... |
| 16.04.2023 | AVITA Medical Announces Update to Automation Device | AVITA Medical, a regenerative medicine company leading the development and commercialization of firs... | aithority.... |
Show more